StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
NPL.BO$561.00-0.46%
Fair $561.00+0.0%

NPL.BO

National Peroxide Limited

Basic Materials / Specialty ChemicalsBSE

$561.00

-2.60 (-0.46%)

Fairly Valued+0.0%Fair Value $561.00Fund rank 36/100 · Data gapFallback financials|
SA 55/C
F-Score: 6/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $217.7M · quality 74.7/100

Data gap 36/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 64/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

55/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is 3.0%, below the 5% threshold
Thesis & Journal · NPL.BOLocal privado en este navegador · National Peroxide Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$3.2B

P/E

29.2x

↑

EV/EBITDA

8.6x

↓

ROE

3.0%

↑

Gross Margin

54.1%

↑

Debt/Equity

0.04

↓
52-Week Range$561
$350$770

TradingView lightweight chart

NPL.BO price, volumen y niveles de valoración

Último $561.00Periodo -38.6%
Fair value: $561.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

-8.3%

FCF CAGR

-21.3%

FCF margin

10.3%

FCF / Net income

2.70x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.90B · net income $110.4M · FCF $297.9M

2023-FY → 2026-FY

Gross margin

54.1%+3.6% pts

Operating margin

3.6%-7.1% pts

Net margin

3.8%-6.7% pts

FCF margin

10.3%-6.0% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$2.90B$2.90B$2.87B$3.31B$3.75B
Net Income$110.4M$110.4M$-22.5M$167.9M$395.0M
EBITDA$365.8M$365.8M$197.0M$427.5M$781.3M
EPS——-3.9129.2268.73
Gross Margin54.1%54.1%48.3%50.2%50.6%
Operating Margin3.6%3.6%-1.7%5.7%10.7%
Net Margin3.8%3.8%-0.8%5.1%10.5%
Balance Sheet
Debt/Equity0.040.040.050.050.07
Current Ratio3.223.22———
Cash Flow
Free Cash Flow$297.9M$297.9M$137.8M$217.7M$611.2M
Returns
ROE3.0%3.0%-0.6%4.7%11.2%
Valuation
P/E29.1929.19———
EV/EBITDA8.658.6517.44——
P/B0.890.890.97——
Growth & Yield
Revenue Growth1.0%1.0%-13.3%-11.9%—
EPS Growth——-113.4%-57.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -6.3%

Total return

-6.3%

Start / end P/E

n/dx → n/dx

EPS bridge

-3.91 → n/d

Residual

-6.3%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-6.3%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.